Inventor · disambiguated record
Yibin Kang
Also filed as: KANG YIBIN
7 granted patents·12 pending applications·7 citations·filing 2008–2024
77Inventor score
Top patents by PatentIndex Score
19 records- 0184US12162855B2Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancersUNIV PRINCETON·Filed 2021·Granted Dec 10, 2024·1 cites·2 claims
- 0284US12054475B2Substituted heterocycles as aldehyde dehydrogenase inhibitorsKAYOTHERA INC·Filed 2023·Granted Aug 6, 2024·1 cites·30 claims
- 0378US10786545B2Use of peptides that block metadherin-SND1 interaction as treatment for cancerUNIV PRINCETON·Filed 2019·Granted Sep 29, 2020·1 cites·19 claims
- 0477US9932587B2Methods of identifying and treating poor prognosis cancersUNIV PRINCETON·Filed 2016·Granted Apr 3, 2018·1 cites·18 claims
- 0576US10357539B2Use of peptides that block metadherin-SND1 interaction as treatment for cancerUNIV PRINCETON·Filed 2015·Granted Jul 23, 2019·3 cites·15 claims
- 0674US2025129046A1Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancersUNIV PRINCETON·Filed 2024·Application pending·0 cites
- 0771US2009324596A1Methods of identifying and treating poor-prognosis cancersUNIV PRINCETON·Filed 2008·Application pending·0 cites
- 0869US10202605B2Methods of identifying and treating poor-prognosis cancersUNIV PRINCETON·Filed 2018·Granted Feb 12, 2019·0 cites·15 claims
- 0966US2024343709A1Substituted heterocycles as aldehyde dehydrogenase inhibitorsKAYOTHERA INC·Filed 2024·Application pending·0 cites
- 1058US2024088963A1Method and apparatus for determining radio channel multipath information and related deviceHUAWEI TECH CO LTD·Filed 2023·Application pending·0 cites
- 1158US2015157716A1Methods Of Identifying And Treating Poor-Prognosis CancersUNIV PRINCETON·Filed 2015·Application pending·0 cites
- 1257US10745701B2Methods of identifying and treating poor-prognosis cancersUNIV PRINCETON·Filed 2018·Granted Aug 18, 2020·0 cites·20 claims
- 1357US2024398767A1Inhibitors of the mtdh-snd1 protein complex for cancer therapyUNIV PRINCETON·Filed 2022·Application pending·0 cites
- 1452US2013309246A1Jagged1 as a marker and therapeutic target for breast cancer bone metastasisKANG YIBIN·Filed 2012·Application pending·0 cites
- 1552US2023128402A1Heterocyclic compounds and uses thereofUNIV PRINCETON·Filed 2021·Application pending·0 cites
- 1648US2015329918A1Jagged1 as a marker and therapeutic target for breast cancer bone metastasisUNIV PRINCETON·Filed 2015·Application pending·0 cites
- 1747US2021379147A1Method and system for treating cancer utilizing tinagl1UNIV PRINCETON·Filed 2019·Application pending·0 cites
- 1845US2016017326A1Micrornas as functional mediators and biomarkers of bone metastasisUNIV PRINCETON·Filed 2014·Application pending·0 cites
- 1941US2020237909A1Methods of treating or preventing breast cancer metastases using antibodies to jagged1 and chemotherapeutic agentsUNIV PRINCETON·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yibin Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →